Ladenburg Thalmann Downgrades United Therapeutics Corp. (UTHR) to Neutral

February 23, 2017 10:06 AM EST Send to a Friend
Ladenburg Thalmann downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Buy to Neutral with a price target of $145.00 (from $138.00).Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login